|
|
|
FDA Home Page | Search
FDA Site | FDA A-Z Index | Contact
FDA
Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857
This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policy makers with persons outside the executive branch of the Federal Government.
 |
February 7, 2005 |
|
|||
|---|---|---|---|---|---|
FDA Official and Title |
Date and Site |
Other FDA Participants |
Non-FDA Participants |
Subject |
|
| Dr. Crawford, Acting Commissioner of FDA | 1/24/05 Rockville, MD | Janet Woodcock, Stephen Galson, Gerald Masoudi, Sheila Walcoff, Susan Bond, and Beth Clarke | John Klippel, Arthritis Foundation (AF); Kevin Bennan, AF; and David Zook, Baker & Daniels | Future collaborations with FDA & AF | |
| Janet Woodcock, M.D., Deputy Commissioner for Operations |
2/2-3/05 Houston, Texas |
Anna D. Barker Gordon B. Mills Samir M. Hanash |
Strategies to Integrate Biomarkers Into Cancer Clinical Trials | ||
| Janet Woodcock, M.D., Deputy Commissioner for Operations |
2/14-15/05 Austin, Texas |
John Koerner | Donald R. Stanski Richard G. |
International Conference on Drug Development | |
| Janet Woodcock, MD Deputy Commissioner for Operations |
2/18/05 Washington, DC |
AAAS Office of Public Programs | AAAS Symposium Annual Meeting | ||
| Michael Landa, Deputy Center Director for Regulations and Policy (ORP) | 2/2/05 Wiley Building College Park, MD Rm. 4B-047 | Joseph Baca, Director, Office of Compliance (OC); John Kvenberg, Deputy Director,Oc;Betty Harden, (OC); Judity Gushee (OC); Katherine Vick, OSAS; Catherine Copp, (ORP); Dr. Nega Beru, (OPDF); Geraldine June, (ONPLDS); Wanda Kelker (ONPLDS); Steve Bradbard; Peter Vardon; and Dr. Anna P. Shanklin (EOS) | Tracie Sheehan, Sara Lee Inc.; Tom Trautman, General Mills; Susan Estes, GMA; Martin Hahn, Hogan and Hartson; Rodney Hayes, McCormick; and Raul Fajardo, McCormick | The Food Allergen Labeling Act | |
| Jesse L. Goodman, M.D., MPH, Director | 1/31/05 Washington, DC | Norman Baylor, PhD, Acting Director, Office of Vaccines Research and Review (OVRR) | Barr. Duramed (Pharmaceuticals) | Interest in developing biologics and vaccines | |